Korea University

HAEL developed a 'semiconductor cancer diagnosis app' detecting cancer in blood, with CEO Kim Jun announcing its potential at Kangwon National University. The app automates recurrence diagnosis using a biochip, aiming to help cancer patients monitor recurrence at home. Hael also completed international patent registration for diagnostic devices and plans to list in the North American market.

Five Korean research teams selected for the 'Global Center Program,' joining international joint research on 'Biodiversity Utilization' and 'Biofoundries' with six countries for five years.